Testing a new eczema ointment for mild to moderate cases
Part of Immune system & allergy, Skin clinical trials.
This study tests a new ointment called IN-115314 for adults with mild to moderate eczema. Researchers want to see if it helps control symptoms like itching and redness better than a placebo, and check that it's safe to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have mild to moderate atopic dermatitis (eczema) diagnosed by a doctor.
- You have had eczema for at least 12 months and it hasn't changed much in the last month.
- You haven't used certain eczema treatments (like steroid creams, oral steroids, or strong medications) in the recent weeks before starting the trial.
- You do not have other serious skin conditions, major health problems, or a history of certain cancers in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ointment (HL-300) designed to treat mild-to-moderate atopic dermatitis (a chronic skin condition causing itching and inflammation). You would apply it to affected skin areas to see if it safely reduces symptoms.
This trial tests a new topical medication for eczema, a chronic itchy skin condition. The goal is to see if it improves symptoms and is safe for people with mild to moderate eczema affecting a limited body area.
This trial tests if an ointment called QLM3003 is safe and helps adults with mild to moderate atopic dermatitis (eczema). It may be a new treatment option for people whose eczema affects small areas of skin.
This trial tests a study drug (PF-08049820) for people with moderate to severe eczema who haven't found a suitable prescription treatment. It aims to see if the drug can improve skin symptoms and itching.
This study tests a new medication (IBI3033) for people with moderate to severe atopic dermatitis (eczema) that hasn't responded well to creams. The goal is to see if it's safe and effective in reducing symptoms like itching and rash.
This study tests a new medication called HXN5003 to see if it is safe and how well it works for people with moderate-to-severe eczema (atopic dermatitis). It may help reduce symptoms like itching and rash.
Hear when a new Mild to Moderate Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.